Globus Medical, Inc. GMED

Healthcare · Medical Devices · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$5.50B
Market Cap
$10.00B
Margin of Safety
-81.8%
Intrinsic / Market Ratio
0.55

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

6.96B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

4.77B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

4.77B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

5.50B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

5.50B USD

from the sum above

Market Cap

10.00B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.55×

the ratio the screener ranks by; Margin of Safety -81.8% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 6.96B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)3.72B USD
+②Net Cash Today484.43M USD
+③Growth Value2.76B USD
=Value6.96B USD

EPV of the Operations (NOPAT over WACC)

3.72B USD

Net cash today

+484.43M USD

Growth Value

+2.76B USD

Value

6.96B USD

①EPV (earnings power value)

3.72B USD

②Net Cash Today

484.43M USD

③Growth Value

2.76B USD

Market value

Market Cap10.00B USD

Today's price times the shares.

Value vs market

Margin of Safety-43.7%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 4.77B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE3.22B USD
+②Equity at Year 15, Today1.55B USD
=Value4.77B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment rising to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

3.22B USD

②Equity at Year 15, Today

1.55B USD

Market value

Market Cap10.00B USD

Today's price times the shares.

Value vs market

Margin of Safety-109.5%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 4.77B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (a change in working capital above half the operating profit in the latest three years), so the value is the book value today, 4.77B USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap10.00B USD

Today's price times the shares.

Value vs market

Margin of Safety-109.5%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 10.17%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.96×Market Risk Premium 6.00%= 10.24%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 67.27M USDPretax Income 605.67M USD= 11.11%

The tax the interest saves.

Interest Expense =EBIT 537.73M USD−Pretax Income 605.67M USD= —

The interest the company paid: EBIT is the profit before tax plus the interest.

No interest is read: it needs debt and an EBIT above the profit before tax, the gap between them being the interest. Without it the cost of debt takes the 4% default.

Cost of Debt 4.00% (default): with no debt or no interest read, the 4% default after tax stands for what the lenders are paid a year.

Debt Weight =Total Debt 111.30M USDMarket Cap + Total Debt 10.00B USD + 111.30M USD= 1.10%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 98.90%×Cost of Equity 10.24%+Debt Weight 1.10%×Cost of Debt 4.00%= 10.17%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 5.49B USD − Total Liabilities 720.37M USD = Book Value Today 4.77B USD

Total Debt 111.30M USD − Cash and Short-Term Investments 595.74M USD = Net Debt Today -484.43M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-1.5%at most 5%passes134,252,287 / 136,335,662
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets3.9%at least -10.0%passes(754.20M USD − 538.41M USD) ÷ 5.49B USD
Price to bookMarket Cap ÷ Book Value Today2.10×at most 3×passes10.00B USD ÷ 4.77B USD
Operating marginOperating Income ÷ Revenue18.3%above 10.0%passes537.73M USD ÷ 2.94B USD
Revenue growthRevenue ÷ Revenue a Year Before − 116.7%above 10.0%passes2.94B USD / 2.52B USD
Net cash(Cash − Total Debt) ÷ Market Cap4.0%above -30%passes(508.25M USD − 111.30M USD) ÷ 10.00B USD
Operating efficiencyOperating Income ÷ Gross Profit27.1%above 25.0%passes537.73M USD ÷ 1.98B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

74 USD

Enterprise value

9.52B USD

market cap plus net debt

EV / EBITDA

9.41×

Price / book

2.09×

the provider's book

Price / earnings

19.03×

Return on equity

11.8%

the provider's, not the engine's

Profit margin

17.0%

Revenue growth

5.9%

Analyst target, mean

101 USD

Analysts

13

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

1.02B1.57B2.52B2.94B

Gross profit

759.88M1.02B1.49B1.98B

Operating income

236.49M201.62M219.61M537.73M

EBITDA

operating income before depreciation and amortisation

304.81M347.29M473.25M814.85M

Pretax income

243.26M165.56M120.84M605.67M

Net income

190.36M123.00M103.09M538.41M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

197.66M163.16M185.64M487.39M

R&D

73.09M124.13M163.92M147.39M
Balance sheet, year end

Total assets

2.08B5.09B5.26B5.31B

Total liabilities

229.98M1.09B1.08B730.24M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

1.85B4.00B4.18B4.58B

Total debt

6.02M520.92M537.73M118.77M

Cash and equivalents

150.62M467.76M785.22M526.68M

Net PP&E

fixed assets after depreciation

249.97M647.51M612.17M628.87M

Working capital

current assets less current liabilities

824.96M1.52B1.32B1.63B
Cash flow

Operating cash flow

178.65M243.74M521.16M754.20M

Capital expenditure

paid out, so below zero

-74.12M-78.35M-115.54M-174.60M

Depreciation and amortisation

68.32M145.67M253.64M277.12M

Free cash flow

operating cash flow plus capital expenditure

104.53M165.39M405.61M579.60M